666

NORTH CHINA PHARMACEUTICAL COMPANY. LTD

No trades
See on Supercharts

600812 fundamentals

NORTH CHINA PHARMACEUTICAL COMPANY. LTD financial statements, including revenue, expenses, profit, and loss

The total revenue of 600812 for the last quarter is 2.53 B CNY, and it's 19.46% higher compared to the previous quarter. The net income of Q1 24 is 18.15 M CNY.

Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
‪0.00‬
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: CNY
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth